88 related articles for article (PubMed ID: 280254)
1. Effect of intraventricular injection of 5,7-dihydroxytryptamine on serum gonadotropins and prolactin.
Wuttke W; Hancke JL; Höhn KG; Baumgarten HG
Ann N Y Acad Sci; 1978 Jun; 305():423-36. PubMed ID: 280254
[No Abstract] [Full Text] [Related]
2. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
[No Abstract] [Full Text] [Related]
3. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
Kantak KM; Hegstrand LR; Eichelman B
Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
[TBL] [Abstract][Full Text] [Related]
4. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
Ishikawa Y; Matuszek M; Nakayama T
Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
[TBL] [Abstract][Full Text] [Related]
5. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine.
Larsson K; Fuxe K; Everitt BJ; Holmgren M; Södersten P
Brain Res; 1978 Feb; 141(2):293-303. PubMed ID: 626904
[No Abstract] [Full Text] [Related]
6. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
[No Abstract] [Full Text] [Related]
7. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
Saller CF; Stricker EM
Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
[No Abstract] [Full Text] [Related]
8. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection.
Barbeau H; Bédard P
Neuropharmacology; 1981 Jun; 20(6):611-6. PubMed ID: 6972494
[No Abstract] [Full Text] [Related]
9. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.
Quattrone A; Schettini G; Annunziato L; Di Renzo G
Eur J Pharmacol; 1981 Nov; 76(1):9-13. PubMed ID: 7318925
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric action of intraventricular monoamine neurotoxins.
Gershanik OS; Heikkila RE; Duvoisin RC
Brain Res; 1979 Oct; 174(2):345-50. PubMed ID: 487133
[No Abstract] [Full Text] [Related]
12. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
Willoughby JO; Menadue M; Jervois P
Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
[TBL] [Abstract][Full Text] [Related]
13. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
14. The ability of local injection of 6-OHDA, 5,6-DHT and 5,7-DHT into the olfactory bulbs to mimic the effects of bilateral bulbectomy in the rat [proceedings].
Cairncross KD; Cox B; Forster C; Wren A
Br J Pharmacol; 1977 Sep; 61(1):145P-146P. PubMed ID: 912193
[No Abstract] [Full Text] [Related]
15. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
Manaker S; Engber TM; Knight PB; Winokur A
J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
17. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
[TBL] [Abstract][Full Text] [Related]
19. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
Applegate CD
Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
[No Abstract] [Full Text] [Related]
20. [Effect of cerebral intraventricular administration of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the cyclic secretion of corticosterone in the rat].
Montilla P; Pinilla J; Muñoz MC; Clavero RM
Rev Esp Fisiol; 1984 Sep; 40(3):333-9. PubMed ID: 6522800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
